A detailed history of Private Trust CO Na transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Private Trust CO Na holds 83 shares of IONS stock, worth $3,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 378 78.04%
Holding current value
$3,295
Previous $16,000 81.25%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$36.45 - $47.7 $10,752 - $14,071
-295 Reduced 78.04%
83 $3,000
Q1 2024

Apr 24, 2024

BUY
$42.03 - $53.55 $462 - $589
11 Added 3.0%
378 $16,000
Q4 2023

Jan 24, 2024

BUY
$43.39 - $51.63 $11,151 - $13,268
257 Added 233.64%
367 $18,000
Q2 2023

Jul 28, 2023

BUY
$34.73 - $43.33 $3,716 - $4,636
107 Added 3566.67%
110 $4,000
Q1 2023

Apr 12, 2023

SELL
$33.58 - $41.2 $1,208 - $1,483
-36 Reduced 92.31%
3 $0
Q2 2022

Sep 16, 2022

BUY
$31.71 - $43.0 $1,236 - $1,677
39 New
39 $1,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.